Prophylaxis and treatment of chronic synovitis in haemophilia patients with inhibitors

被引：7
|
作者：
Rodriguez-Merchan, E. C.
Valentino, L.
Quintana, M.
机构：
[1] La Paz Univ Hosp, Dept Orthopaed, Madrid, Spain
[2] La Paz Univ Hosp, Haemophilia Unit, Madrid, Spain
[3] Rush Presbyterian St Lukes Med Ctr, Dept Haematol, Chicago, IL 60612 USA
[4] La Paz Univ Hosp, Dept Haematol, Madrid, Spain
来源：
HAEMOPHILIA | 2007年 / 13卷
关键词：
haemophilia; inhibitors; prophylaxis; radiactive synoviorthesis; synovitis;
D O I：
10.1111/j.1365-2516.2007.01540.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Prophylaxis is paramount to try to avoid the development of haemophilic synovitis. The best treatment for synovitis in patients with inhibitors is radioactive synoviorthesis (rhenium for ankle and elbows, yttrium for knees). With both methods (prohylaxis and radioactive synoviorthesis), we can delay the development of severe haemophilic arthropathy, that eventually will require major orthopaedic surgery.
引用
收藏
页码：45 / 48
页数：4
相关论文
共 50 条
  • [31] Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors
    Cortesi, Paolo Angelo
    Castaman, Giancarlo
    Trifiro, Gianluca
    Creazzola, Simona Serao
    Improta, Giovanni
    Mazzaglia, Giampiero
    Molinari, Angelo Claudio
    Mantovani, Lorenzo Giovanni
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (02) : 216 - 228
  • [32] The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report
    Valentino, L. A.
    Carcao, M.
    Mathew, P.
    Leissinger, C. A.
    Berntorp, E.
    Blanchette, V.
    Escuriola-Ettingshausen, C.
    Ewenstein, B.
    Ewing, N.
    Gringeri, A.
    Hoots, W. K.
    Negrier, C.
    HAEMOPHILIA, 2009, 15 (04) : 959 - 965
  • [33] Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors
    Eva Mingot-Castellano, Maria
    Teresa Alvarez-Roman, Maria
    Fernanda Lopez-Fernandez, Maria
    Altisent-Roca, Carmen
    Isabel Canaro-Hirnyk, Mariana
    Jimenez-Yuste, Victor
    Rosa Cid-Haro, Ana
    Perez-Garrido, Rosario
    Sedano-Balbas, Carmen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (05) : 461 - 474
  • [34] Long term follow up of secondary prophylaxis with RFVIIA in haemophilia patients with inhibitors
    Torres, O. W.
    Nascimento, P. D.
    Arbesu, G.
    Borchichi, S.
    Buceta, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 368 - 369
  • [35] Treatment of chronic hepatitis C in haemophilia patients
    Meijer, K
    Smid, WM
    Van der Meer, J
    HAEMOPHILIA, 2000, 6 (06) : 605 - 613
  • [36] Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis
    Batsuli, Glaivy
    Zimowski, Karen L.
    Tickle, Kelly
    Meeks, Shannon L.
    Sidonio, Robert F., Jr.
    HAEMOPHILIA, 2019, 25 (05) : 789 - 796
  • [37] Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors
    Gringeri, A
    Mannucci, PM
    HAEMOPHILIA, 2005, 11 (06) : 611 - 619
  • [38] Synoviorthesis in the Treatment of Recurrent Hemarthrosis in Haemophilia Patients with Inhibitors
    Querol-Giner, M.
    Perez-Alenda, S.
    Iradi, A.
    Carrasco, J. J.
    Calatayud, J.
    Casana, J.
    Bonanad, S.
    Querol-Fuentes, F.
    HAEMOPHILIA, 2016, 22 : 24 - 24
  • [39] Inhibitors in patients with haemophilia A
    Kreuz, Wolfhart
    Ettingshausen, Carmen Escuriola
    THROMBOSIS RESEARCH, 2014, 134 : S22 - S26
  • [40] Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia
    Hanley, J.
    McKernan, A.
    Creagh, M. D.
    Classey, S.
    McLaughlin, P.
    Goddard, N.
    Briggs, P. J.
    Frostick, S.
    Giangrande, P.
    Wilde, J.
    Thachil, J.
    Chowdary, P.
    HAEMOPHILIA, 2017, 23 (04) : 511 - 520
12345